Viruses

BIO5 researcher, Dr. Deepta Bhattacharya, joins the conversation about how the immunity generated from a COVID-19 infection was found to be “at least as high, if not higher” than that provided by two doses of an mRNA vaccine.

Dr. Deepta Bhattacharya talks to STAT about how the virus that causes COVID has perplexed scientists, and how COVID policies have been received by the public -- sharing examples from his own family.

A CDC report shows the flu is sending more people to the hospital this year than it has in a decade. The number of children being hospitalized with bugs is particularly alarming. And now, there’s a new COVID-19 subvariant making the rounds. When it comes to the surge in sickness, many health experts believe the culprit is something called “immunity debt,” and we’re struggling to pay up.

Dr. Purnima Madhivanan has received The Health Gamechanger Award which honors a community member who actively seeks health equality for all Americans, including a healthy life and high-quality health care.

UArizona Health Sciences is one of five sites that will be tracking the burden, distribution and impact of post COVID-19 conditions.

UArizona Immunologist Dr. Deepta Bhattacharya weighs in on why kids are getting hit hard by respiratory viruses. Dr. Bhattacharya & experts around the globe share what scientists know about the resurgence of childhood respiratory viruses- and what they don't.

A UArizona lab led by Dr. Ian Pepper which launched the first tests for COVID-19 in wastewater is now turning its attention to chemicals called PFAS seeping into Pima County groundwater.

Hyeon Seung Lee is a senior at UArizona working in the Chang Lab. He and the lab are studying the underlying mechanisms of chronic sinusitis and its associated virus called rhinovirus, the most frequent cause of the common cold.

Dr. Melissa Herbst-Kralovetz an associate professor at the UArizona College of Medicine - Phoenix received the J. Christian Herr Award from the American Society for Reproductive Immunology (ASRI) for her work in technology transfer that will positively impact women.

A vaccine strategy involving formulation changes, an initial escalating dose, and a longer wait for booster immunization results in more-effective antibody production against HIV in rhesus monkeys, a study finds.